CCRN's Q1 2026 10-Q reflects a healthcare staffing company in sustained operational decline with a merger agreement announced as a subsequent event. Under a liquidation lens, the recovery posture is marginally positive at the consolidated level but thin relative to book equity, and the merger price ($13.25/share, implying roughly $414M enterprise value on ~31.2M shares) provides the clearest market signal of liquidation-proximate value. Applying standard haircuts: cash of $105.6M recovers at 100%; net AR (billed $176.6M less allowance $8.7M, plus unbilled $54.5M) recovers at 90-95%, yielding roughly $205-215M; prepaid/other current assets ($7.4M + $1.3M + $4.3M insurance receivable + $3.1M tax receivable) recover at modest haircuts, contributing ~$13M. PP&E net of $27.3M recovers at 50-70%, yielding $14-19M. Intangibles net ($25.8M finite-lived) and goodwill ($63.8M) receive 0% recovery under liquidation assumptions. Total gross haircutted asset recovery is approximately $338-352M. Liability stack at face: current liabilities $90.6M (accrued payroll $39.5M, AP/accrued $47.6M, operating lease current $1.0M, other current $2.5M), plus non-current: insurance/claims liability $30.0M, deferred compensation $2.2M, deferred tax liability $2.7M, uncertain tax positions $10.5M, other non-current $1.2M + $1.1M operating lease. Total liabilities at face: ~$138.3M. Estimated liquidation recovery to equity: $338-352M minus $138M = approximately $200-214M, against book equity of $312.8M. The $30.2M deferred tax valuation allowance (established Q4 2025, grown marginally to $30.2M from $29.7M at year-end) signals management's own assessment that domestic deferred tax assets are not realizable, consistent with the three-year cumulative pre-tax loss trajectory. The $10.5M uncertain tax position liability is at face in the liability stack and represents incremental exposure. A $14.2M termination fee is payable by CCRN if the merger is terminated under certain company-side conditions, and receivable from Parent if terminated on antitrust grounds — this contingent liability/receivable is symmetric and not separately tagged in XBRL. The Company's insurance settlement receivables ($4.3M current, $14.3M non-current) are carried on the asset side but their recoverability depends on pending insurance outcomes; under liquidation, recovery is uncertain. The ABL has zero drawn balance with $91M net availability, imposing no incremental liquidation liability. Revenue continues to decline (-17.8% YoY to $241.1M), narrowing the operating base underpinning any going-concern value premium, but the merger agreement at $13.25/share provides a near-term resolution event that makes this liquidation analysis largely academic.
▼ Community Notes